A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners. (Q53915629)

22 May 2018

title

A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners. (English)

1 reference

22 May 2018

author name string

Davies JS

1

1 reference

22 May 2018

Obuobie K

2

1 reference

22 May 2018

Smith J

3

1 reference

22 May 2018

Rees DA

4

1 reference

22 May 2018

Furlong A

5

1 reference

22 May 2018

Davies N

6

1 reference

22 May 2018

Evans LM

7

1 reference

22 May 2018

Scanlon MF

8

1 reference

22 May 2018

publication date

1 March 2000

1 reference

22 May 2018

published in

Clinical Endocrinology

1 reference

22 May 2018

volume

52

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

295-303

1 reference

22 May 2018

Increased cerebrovascular mortality in patients with hypopituitarism

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

The growth hormone deficiency syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Clinical aspects of growth hormone deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Factors influencing the desire for long-term growth hormone replacement in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Characteristics of adults who wish to enter a trial of growth hormone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

21 January 2018

Less heat, more light

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Replacement therapy should be offered to adults with severe growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Guidelines for optimizing growth hormone replacement therapy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00964.X

10.1046/J.1365-2265.2000.00964.X

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018